Aju Pharm   Report issue

For profit Phase 1 Phase 2
Founded: Seoul Korea, Republic of (1953)
Status: No NME R&D (1953)

Organization Overview

First Clinical Trial
2015
NCT02439385
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

AJU Pharm Co., Ltd.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colorectal Neoplasms (Phase 2)

Neoplasm Metastasis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 11